Koyfin Home > Directory > Health Care > Revance Therapeutics > Price / Sales (ltm)

Revance Therapeutics Price / Sales (ltm) Chart (RVNC)

Revance Therapeutics annual/quarterly Price / Sales (ltm) from 2018 to 2019.
  • Revance Therapeutics Price / Sales (ltm) for the quarter ending November 11, 2019 was 222.28 a 2.16% increase of 4.80 year over year
  • Revance Therapeutics Price / Sales (ltm) for the last 12 months ending November 11, 2019 was 222.28 a 2.16% increase of 4.80 year over year
  • Revance Therapeutics Annual Price / Sales (ltm) for 2019 was 222.28 a 0.63% increase of 1.41 from 2018
  • Revance Therapeutics Annual Price / Sales (ltm) for 2019 was 220.87 a -0.19% decrease of -0.42 from 2018
  • Revance Therapeutics Annual Price / Sales (ltm) for 2019 was 221.29 a 1.72% increase of 3.81 from 2018
Other Valuation Metrics:
  • Revance Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,131m a 29.36% increase of 332m year over year
  • Revance Therapeutics Price / Book for the quarter ending March 03, 2018 was 4.18 a -6.42% decrease of -0.27 year over year
  • Revance Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $850m a 27.67% increase of 235m year over year
View Chart On Koyfin

Quarterly RVNC Price / Sales (ltm) Data

11/2019222.28
10/2019220.87
10/2019221.29
10/2019217.48
10/2019215.08
10/2019216.92
10/2019214.94
10/2019217.20
10/2019215.22
10/2019221.01

Annual RVNC Price / Sales (ltm) Data

2019222.28
2019220.87
2019221.29
2019217.48
2019215.08
2019216.92
2019214.94
2019217.20
2019215.22
2019221.01